Emergent BioSolutions (EBS) Retained Earnings (2010 - 2026)
Emergent BioSolutions (EBS) posted Retained Earnings of $951.8 million for Q2 2026, up 0.77% on a QoQ basis from $944.5 million in Q1 2026, and up 1.78% year-over-year from $935.2 million in Q2 2025.
Powered by 
Analysis
Emergent BioSolutions (EBS) Retained Earnings (2010 - 2026) Analysis & Trends
Emergent BioSolutions has reported Retained Earnings for 17 years, with the latest figure at $951.8 million in Q2 2026.
- On a quarterly basis, Retained Earnings rose 1.78% year-over-year to $951.8 million in Q2 2026; TTM through Jun 2026 was $951.8 million, a 1.78% increase from a year earlier, with the FY2025 full-year figure at $942.4 million, up 1.55% from the prior year.
- Retained Earnings was $951.8 million for Q2 2026 at Emergent BioSolutions, up from $944.5 million in the prior quarter.
- The five-year high for Retained Earnings was $954.1 million in Q1 2022, with the low at $860.1 million in Q3 2022.
- Average Retained Earnings over 5 years is $915.8 million, with a median of $919.8 million recorded in 2024.
- The largest YoY upside for Retained Earnings was 19.77% in 2022 against a maximum downside of 8.08% in 2022.
- Over 5 years, Retained Earnings stood at $873.5 million in 2022, then climbed by 3.54% to $904.4 million in 2023, then climbed by 2.61% to $928.0 million in 2024, then advanced by 1.55% to $942.4 million in 2025, then rose by 1.0% to $951.8 million in 2026.
- The last three Retained Earnings figures came in at $951.8 million (Q2 2026), $944.5 million (Q1 2026), and $942.4 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.47 Bn | 628.71 Bn | 17.26 Bn | 171.67 Bn |
| 2 | AbbVie | 467.46 Bn | 460.93 Bn | 12.70 Bn | -17.33 Bn |
| 3 | Merck | 369.31 Bn | 362.22 Bn | 12.21 Bn | 63.27 Bn |
| 4 | Novartis Ag | 269.03 Bn | 261.74 Bn | 11.24 Bn | 40.86 Bn |
| 5 | Pfizer | 158.11 Bn | 146.71 Bn | 10.94 Bn | 112.09 Bn |
| 6 | Bristol Myers Squibb | 127.96 Bn | 116.89 Bn | 9.25 Bn | 46.50 Bn |
| 7 | Sanofi | 51.83 Bn | 44.86 Bn | 10.79 Bn | - |
| 8 | BeOne Medicines | 41.33 Bn | 36.23 Bn | 1.53 Bn | 13.05 Bn |
| 9 | Revolution Medicines | 41.30 Bn | 41.30 Bn | - | -4.00 Bn |
| 10 | Emergent BioSolutions | 335.50 Mn | 194.60 Mn | 137.20 Mn | 951.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 951.80 Mn |
| Mar 31, 2026 | 944.50 Mn |
| Dec 31, 2025 | 942.40 Mn |
| Sep 30, 2025 | 938.60 Mn |
| Jun 30, 2025 | 935.20 Mn |
| Mar 31, 2025 | 930.80 Mn |
| Dec 31, 2024 | 928.00 Mn |
| Sep 30, 2024 | 924.40 Mn |
| Jun 30, 2024 | 915.30 Mn |
| Mar 31, 2024 | 909.80 Mn |
| Dec 31, 2023 | 904.40 Mn |
| Sep 30, 2023 | 899.70 Mn |
| Jun 30, 2023 | 895.80 Mn |
| Mar 31, 2023 | 878.20 Mn |
| Dec 31, 2022 | 873.50 Mn |
| Sep 30, 2022 | 860.10 Mn |
| Jun 30, 2022 | 897.70 Mn |
| Mar 31, 2022 | 954.10 Mn |
| Dec 31, 2021 | 950.30 Mn |
| Sep 30, 2021 | 816.80 Mn |
API Access
Emergent BioSolutions Retained Earnings API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=retained-earnings&ticker=EBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "retained-earnings", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=retained-earnings&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();